| Mechanism of interaction between autophagy and apoptosis in cancer S Das, N Shukla, SS Singh, S Kushwaha, R Shrivastava Apoptosis, 1-22, 2021 | 135 | 2021 |
| Attributes of alternatively activated (M2) macrophages R Shrivastava, N Shukla Life sciences 224, 222-231, 2019 | 92 | 2019 |
| Therapeutic targeting of poly (ADP‐ribose) polymerase‐1 (PARP1) in cancer: Current developments, therapeutic strategies, and future opportunities J Rajawat, N Shukla, DP Mishra Medicinal Research Reviews 37 (6), 1461-1491, 2017 | 57 | 2017 |
| Skp2 inhibits osteogenesis by promoting ubiquitin–proteasome degradation of Runx2 G Thacker, Y Kumar, MP Khan, N Shukla, I Kapoor, JK Kanaujiya, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (4), 510-519, 2016 | 35 | 2016 |
| Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains SM Roelle, N Shukla, AT Pham, AM Bruchez, KA Matreyek PLoS Biology 20 (7), e3001738, 2022 | 26 | 2022 |
| Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection N Shukla, SM Roelle, VG Suzart, AM Bruchez, KA Matreyek PLoS pathogens 17 (7), e1009715, 2021 | 25 | 2021 |
| Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking … S Krishna, AD Lakra, N Shukla, S Khan, DP Mishra, S Ahmed, MI Siddiqi Journal of Biomolecular Structure and Dynamics 38 (11), 3280-3295, 2020 | 14 | 2020 |
| Ubiquitin ligase, Fbw7, targets CDX2 for degradation via two phosphodegron motifs in a GSK3β-dependent manner Y Kumar, N Shukla, G Thacker, I Kapoor, S Lochab, MLB Bhatt, ... Molecular Cancer Research 14 (11), 1097-1109, 2016 | 13 | 2016 |
| Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor MIS Maninder Singh, Jyotika Rajawat, Jitendra Kuldeep, Nidhi Shukla, DP. Mshra Journal of biomolecular Structure & Dynamics, 2021 | 7* | 2021 |
| Bacterial metabolic fitness during pathogenesis S Pandey, N Shukla, SS Singh, D Tripathi, T Tripathi, S Kant Microbial Versatility in Varied Environments: Microbes in Sensitive …, 2020 | 2 | 2020 |
| PARP1 inhibition impedes Warburg effect in breast cancer cells through modulation of the miR-98/STAT3 signaling axis N Shukla Cancer Research 78 (13_Supplement), 4425-4425, 2018 | 1 | 2018 |
| Poly (ADP-Ribose) polymerase 1: a therapeutic hope in gynecologic cancers J Rajawat, N Shukla, DP Mishra Front Biosci (Schol Ed) 9, 343-356, 2017 | 1 | 2017 |
| Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage KAM Nidhi Shukla, Sarah M. Roelle, John C. Snell, Olivia DelSignore, Anna M ... Plos Pathogens, 2024 | | 2024 |
| LRIG1 engages ligand VISTA and impairs tumor-specific CD8+ T cell responses TCANDLILW HIEU MINH TA, DIA ROY, KEMAN ZHANG, TYLER ALBAN , IVAN JURIC, JUAN ... Science immunology, 2024 | | 2024 |
| Multiplex measurements of the impacts of ACE2 sequence and cell surface abundance during SARS-like coronavirus entry N Shukla, N Kamath, S Roelle, A Bruchez, K Matreyek The Journal of Biological Chemistry 299 (3), 104011, 2023 | | 2023 |
| 1537 Fighting against the pandemic or threatening the environment? Unforeseen challenges during COVID-19 pandemic A Jaiswal, N Shukla, SS Singh, R Shrivastava, A Santra, A Jaiswal, ... International Journal of Epidemiology 50 (Supplement_1), dyab168. 318, 2021 | | 2021 |
| MicroRNA‐203 regulates cell junction and adhesion proteins by modulating Zeb1/Vimentin axis in breast cancer cells after PARP1 inhibition. N Shukla, J Rajawat, DP Mishra The FASEB Journal 32, 804.12-804.12, 2018 | | 2018 |
